{
  "Gene": "a-synuclein",
  "variants": [
    {
      "cDNA Change": {
        "transcript": "exons 2-4",
        "ref": "N.D.",
        "alt": "N.D.",
        "position": "N.D."
      },
      "Protein Change": {
        "ref": "N.D.",
        "alt": "amphipathic a-helix",
        "position": "N.D."
      },
      "Description in input context": "induction of an amphipathic a-helix at the N terminus (exons 2-4) of a-synuclein upon exposure to phospholipid vesicles"
    },
    {
      "cDNA Change": {
        "transcript": "exons 4",
        "ref": "N.D.",
        "alt": "N.D.",
        "position": "56 -102"
      },
      "Protein Change": {
        "ref": "N.D.",
        "alt": "N.D.",
        "position": "N.D."
      },
      "Description in input context": "Deletion of residues 56 -102 (exon 4) decreases PLD2 inhibition significantly"
    },
    {
      "cDNA Change": {
        "transcript": "exons 6",
        "ref": "N.D.",
        "alt": "N.D.",
        "position": "130-140"
      },
      "Protein Change": {
        "ref": "N.D.",
        "alt": "N.D.",
        "position": "N.D."
      },
      "Description in input context": "Deletion of C-terminal residues 130-140 (exon 6) completely abolishes inhibitory activity"
    },
    {
      "cDNA Change": {
        "transcript": "exons 5 and 6",
        "ref": "N.D.",
        "alt": "N.D.",
        "position": "125 and 136"
      },
      "Protein Change": {
        "ref": "N.D.",
        "alt": "phosphorylation",
        "position": "N.D."
      },
      "Description in input context": "PLD2 inhibition is blocked by phosphorylation at serine 129 or at tyrosine residues 125 and 136, or by mutations that mimic phosphorylation at these sites"
    },
    {
      "Gene": "a-synuclein",
      "variants": [
        {
          "cDNA Change": {
            "transcript": "A53T",
            "ref": "N.D.",
            "alt": "A53T",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Description in input context": "The PD-associated mutant A53T, however, is a more potent inhibitor of PLD2 than is wild-type a-synuclein"
        }
      ]
    }
  ]
}